Atom Bioscience Secures $82M Series D to Advance Gout Treatment ABP-671
China-based Atom Bioscience, known formally as Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd, has reportedly...
Atom Bioscience and Pharmaceutical
Atom Bioscience Initiates Global Phase III Clinical Study for Gout Drug ABP-671
China-based Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd) has announced the enrollment of...
Atom Bioscience’s ABP-671 Shows Positive Phase IIa Results in Gout Treatment
China-based Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd) has announced positive results from...